|Articles|April 8, 2011

Testofen Male Libido Study Published

The double-blind, randomized, placebo-controlled trial performed on 60 healthy males without erectile dysfunction.

Gencor Nutrients Inc. (Anaheim, CA) announced that a human clinical study performed on its Testofen ingredient for healthy libido has been published in Phytotherapy Research.

The double-blind, randomized, placebo-controlled trial performed on 60 healthy males without erectile dysfunction found that a 600-mg dose of Testofen daily resulted in significant positive changes in sexual cognition, sexual arousal, sexual experience, and orgasm, and may assist in maintaining normal testosterone levels.

From ingredient science to consumer trends, get the insights you need to stay competitive in the nutrition industry. Subscribe to Nutritional Outlook today.

Testofen Male Libido Study Published

Related Content

FAQ: How the Shift to PMOS Reshapes Women's Supplement Innovation

Menopause Nutraceutical Market Expands Through Clinical Research and Targeted Innovation

Expanding Women’s Wellness: Skin and Hair Health Research and Developments

New Vision for Women's Health: Trends and Innovation That Push the Category Forward

Women’s Health Innovation: Gut-Ovary Axis and Traditional Botanicals

Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends

FEMA GRAS Recognition Expands Regulatory Pathway for Layn Natural Ingredients’ Stevia Sweetener

Nutrition Requirements in Medical Training Are Expanding: Here's What the Industry Should Know

High-Dose Ashwagandha Root Extract Demonstrates Safety and Tolerability in Clinical Trial

Sabinsa's Tetrahydrocurcuminoids Ingredient Receives Great Britain Novel Food Authorization

Satiety Benefits Extend Beyond Weight Management to Support Metabolic Health